Alitalo K - Search Results

1

VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart.

Kivelä R, Bry M, Robciuc MR, Räsänen M, Taavitsainen M, Silvola JM, Saraste A, Hulmi JJ, Anisimov A, Mäyränpää MI, Lindeman JH, Eklund L, Hellberg S, Hlushchuk R, Zhuang ZW, Simons M, Djonov V, Knuuti J, Mervaala E, Alitalo K. Kivelä R, et al. Among authors: alitalo k. EMBO Mol Med. 2014 Mar;6(3):307-21. doi: 10.1002/emmm.201303147. Epub 2014 Jan 21. EMBO Mol Med. 2014. PMID: 24448490 Free PMC article.

2

Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction.

Vainikka S, Partanen J, Bellosta P, Coulier F, Birnbaum D, Basilico C, Jaye M, Alitalo K. Vainikka S, et al. Among authors: alitalo k. EMBO J. 1992 Dec;11(12):4273-80. doi: 10.1002/j.1460-2075.1992.tb05526.x. EMBO J. 1992. PMID: 1385111 Free PMC article.

3

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.

Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. Joukov V, et al. Among authors: alitalo k. EMBO J. 1996 Jan 15;15(2):290-98. EMBO J. 1996. PMID: 8617204 Free PMC article.

4

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.

Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. Jeltsch M, et al. Among authors: alitalo k. Science. 1997 May 30;276(5317):1423-5. doi: 10.1126/science.276.5317.1423. Science. 1997. PMID: 9162011

5

Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia.

Enholm B, Paavonen K, Ristimäki A, Kumar V, Gunji Y, Klefstrom J, Kivinen L, Laiho M, Olofsson B, Joukov V, Eriksson U, Alitalo K. Enholm B, et al. Among authors: alitalo k. Oncogene. 1997 May 22;14(20):2475-83. doi: 10.1038/sj.onc.1201090. Oncogene. 1997. PMID: 9188862

6

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K. Joukov V, et al. Among authors: alitalo k. EMBO J. 1997 Jul 1;16(13):3898-911. doi: 10.1093/emboj/16.13.3898. EMBO J. 1997. PMID: 9233800 Free PMC article.

7

Vascular endothelial growth factors VEGF-B and VEGF-C.

Joukov V, Kaipainen A, Jeltsch M, Pajusola K, Olofsson B, Kumar V, Eriksson U, Alitalo K. Joukov V, et al. Among authors: alitalo k. J Cell Physiol. 1997 Nov;173(2):211-5. doi: 10.1002/(SICI)1097-4652(199711)173:2<211::AID-JCP23>3.0.CO;2-H. J Cell Physiol. 1997. PMID: 9365524 Review. No abstract available.

8

Vascular endothelial growth factor (VEGF) and VEGF-C show overlapping binding sites in embryonic endothelia and distinct sites in differentiated adult endothelia.

Lymboussaki A, Olofsson B, Eriksson U, Alitalo K. Lymboussaki A, et al. Among authors: alitalo k. Circ Res. 1999 Nov 26;85(11):992-9. doi: 10.1161/01.res.85.11.992. Circ Res. 1999. PMID: 10571529

9

Signaling via vascular endothelial growth factor receptors.

Petrova TV, Makinen T, Alitalo K. Petrova TV, et al. Among authors: alitalo k. Exp Cell Res. 1999 Nov 25;253(1):117-30. doi: 10.1006/excr.1999.4707. Exp Cell Res. 1999. PMID: 10579917 Review.

10

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Mäkinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S, Ylä-Herttuala S, Alitalo K. Mäkinen T, et al. Among authors: alitalo k. Nat Med. 2001 Feb;7(2):199-205. doi: 10.1038/84651. Nat Med. 2001. PMID: 11175851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

721 results

Search Page